Northpond Labs supports Wyss Institute's Lab-on-a-Molecule project, the third Wyss project to receive support from Northpond Labs as part of a strategic research collaboration.

A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory tests.

Five teams of Harvard researchers will work to de-risk promising ideas, with the aim of eventually launching startups, thanks to funding announced today from the University’s Grid Accelerator.

RoboBee project’s micro-fabrication technique pollinates surgical breakthroughs.